首页> 外文期刊>Open access Emergency Medicine >Clinical decision aids for chest pain in the emergency department: identifying low-risk patients
【24h】

Clinical decision aids for chest pain in the emergency department: identifying low-risk patients

机译:急诊科胸部疼痛的临床决策辅助工具:确定低危患者

获取原文
           

摘要

Chest pain is one of the most common presenting complaints in the emergency department, though only a small minority of patients are subsequently diagnosed with acute coronary syndrome (ACS). However, missing the diagnosis has potential for significant morbidity and mortality. ACS presentations can be atypical, and their workups are often prolonged and costly. In order to risk-stratify patients and better direct the workup and care given, many decision aids have been developed. While each may have merit in certain clinical settings, the most useful aid in the emergency department is one that finds all cases of ACS while also identifying a substantial subset of patients at low risk who can be discharged without stress testing or coronary angiography. This review describes several of the chest pain decision aids developed and studied through the recent past, starting with the thrombolysis in myocardial infarction (TIMI) risk score and Global Registry of Acute Coronary Events (GRACE) scores, which were developed as prognostic aids for patients already diagnosed with ACS, then subsequently validated in the undifferentiated chest pain population. Asia-Pacific Evaluation of Chest Pain Trial (ASPECT); Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins (ADAPT); North American Chest Pain Rule (NACPR); and History, Electrocardiogram, Age, Risk factors, Troponin (HEART) score have been developed exclusively for use in the undifferentiated chest pain population as well, with improved performance compared to their predecessors. This review describes the relative merits and limitations of these decision aids so that providers can determine which tool fits the needs of their clinical practice setting.
机译:胸痛是急诊科中最常见的主诉之一,尽管随后只有极少数患者被诊断出患有急性冠状动脉综合征(ACS)。但是,缺少诊断可能会导致高发病率和高死亡率。 ACS演示可能是非典型的,并且其检查通常需要较长时间且费用昂贵。为了对患者进行风险分层并更好地指导检查和护理,已经开发了许多决策辅助工具。虽然每个人在某些临床情况下都有其优点,但急诊科最有用的帮助是查找所有ACS病例,同时还识别出大量的低危患者,这些患者无需进行压力测试或冠状动脉造影即可出院。这篇综述描述了最近开发和研究的几种胸痛决策辅助工具,从心肌梗塞溶栓(TIMI)风险评分和急性冠脉事件全球登记册(GRACE)评分开始,这些都是为患者的预后辅助手段而开发的已经被诊断为ACS,随后在未分化的胸痛人群中进行了验证。亚太地区胸痛试验评估(ASPECT);使用当代肌钙蛋白(ADAPT)评估患有胸痛症状的患者的加速诊断方案;北美胸痛法则(NACPR);和历史,心电图,年龄,危险因素,肌钙蛋白(HEART)评分也专门用于未分化的胸痛人群,与前者相比,性能得到了改善。这篇综述描述了这些决策辅助工具的相对优缺点,以便提供者可以确定哪种工具适合其临床实践环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号